Key topics for European forum 2023

• Dual Mechanism Anti-VEGF Therapies vs Novel Formulations of Older Agents: Will patients and Providers have a Preference?
• Can AI and Digital Health Accelerate the Execution or Reduce the cost of clinical trials?
• Visual Preservation in Retinal Diseases: Will Gene Therapy Make a Dent?
• Investment in Back of the Eye Products: Is it Safer than Buying Cryptocurrency?
• Sustained Delivery for Anti-VEGF Therapy: Come and Gone, or Still in Play?
• Global Harmonization of Regulatory Processes for Drugs and Biologics: The Impact on Retinal Disease and Therapy
• Novel Therapies for Geographic Atrophy: How do we measure success for physicians, patients and payers?

The scientifc program has not been published yet. We will update any information asap.

Please contact the organizer for further information.